Regional stimulation of cholinergic function by nerve growth factor in an animal model of Alzheimer's disease
Williams, L.R.; Jodelis, K.S.; Donald, M.R.
Progress in Clinical and Biological Research 317: 1179-1192
1989
ISSN/ISBN: 0361-7742 PMID: 2602407 Document Number: 340209
Document emailed within 1 workday
Related Documents
Fisher, A.; Brandeis, R.; Karton, I.; Pittel, Z.; Gurwitz, D.; Haring, R.; Sapir, M.; Levy, A.; Heldman, E. 1991: (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease Journal of Pharmacology and Experimental Therapeutics 257(1): 392-403Mufson, E.J.; Kordower, J.H. 1989: Nerve growth factor receptor expressing human basal forebrain neurons: pathologic alterations in Alzheimer's and Parkinson's disease Progress in Clinical and Biological Research 317: 401-414
Markova, E.G.; Isaev, N.K. 1992: Effects of nerve growth factor on the development of the dendritic system of cholinergic neurons in dissociated culture of the rat septum Biulleten' Eksperimental'noi Biologii i Meditsiny 113(3): 318-320
Zhang, W.; Wang, P.-j.; Gu, G.-j.; Li, M.-h.; Gao, X.-l. 2013: Effects of neural stem cells transplanted into an animal model of Alzheimer disease on Aβ plaques Zhonghua Yi Xue Za Zhi 93(45): 3636-3639
Oron, L.; Dubovik, V.; Novitsky, L.; Eilam, D.; Michaelson, D.M. 1997: Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer's disease Journal of Neural Transmission. Supplementum 49: 77-84
Sieroń, A.; Lewin-Kowalik, J. 1988: Nerve growth factor, its chemical structure and biological function Postepy Biochemii 34(3): 173-182
Wang, J.-H.; Li, W.-T.; Yu, S.-T.; Xie, H.; Han, H.-R. 2014: Catalpol regulates function of hypothalamic-pituitary-adrenocortical-axis in an Alzheimer's disease rat model Die Pharmazie 69(9): 688-693
Meng, Q.H.; Lou, F.L.; Hou, W.X.; Liu, M.; Guo, H.; Zhang, X.M. 2013: Acetylpuerarin reduces inflammation and improves memory function in a rat model of Alzheimer's disease induced by Abeta1-42 Die Pharmazie 68(11): 904-908
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Povarina, P.I.; Gudasheva, T.A.; Vorontsova, O.N.; Nikolaev, S.V.; Antipova, T.A.; Ostrovskaia, R.U.; Seredin, S.B. 2012: Neuroprotective effects of a dipeptide mimetic on the GK-2 nerve growth factor in model of permanent common carotid artery occlusion in rats Eksperimental'naia i Klinicheskaia Farmakologiia 75(9): 15-20
Matsuoka, T.; Maeda, Y.; Matsuo, K.; Naiki, Y.; Tamai, Y.; Sakaguchi, M.; Hasegawa, H.; Funauchi, M.; Kanamaru, A. 2008: Hepatocyte growth factor prevents peritoneal fibrosis in an animal model of encapsulating peritoneal sclerosis Journal of Nephrology 21(1): 64-73
Lawrence, A.D.; Sahakian, B.J. 1995: Alzheimer disease, attention, and the cholinergic system Alzheimer Disease and Associated Disorders 9(Suppl 2): 43-49
Kurz, A.; Rüster, P.; Romero, B.; Zimmer, R. 1986: Cholinergic treatment strategies in Alzheimer's disease Der Nervenarzt 57(10): 558-569
Bradley, R.J.; Edge, M.T.; Freeman, A.M. 1991: The effects of cholinergic preparations in Alzheimer's disease Farmakologiia i Toksikologiia 54(3): 4-10
Scott, J.; Selby, M.J.; Bell, G.I. 1987: Isolation of complementary DNA encoding mouse nerve growth factor and epidermal growth factor Methods in Enzymology 147: 194-207
Tucek, S. 1987: Cholinergic mechanisms in the brain and their impairment in Alzheimer's disease Ceskoslovenska Psychiatrie 83(1): 36-45
Clader, J.W. 1999: Recent advances in cholinergic drugs for Alzheimer's disease Current Opinion in Drug Discovery and Development 2(4): 311-320
Mukhin, V.N. 2013: Pathogenesis of the basal forebrain cholinergic dysfunction in Alzheimer's disease Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 99(7): 793-804
Pomara, N.; Stanley, M. 1986: The cholinergic hypothesis of memory dysfunction in Alzheimer's disease--revisited Psychopharmacology Bulletin 22(1): 110-118
Robert, P.H.; Gokalsing, E.; Bertogliati, C. 1999: Cholinergic hypothesis and Alzheimer's disease: the place of donepezil (Aricept) L'Encephale 25(Special Issue 5): 23-27; Discussion: 28-29